About Cornucopian Capital
Cornucopian Capital is a venture capital firm founded in 2020. It is primarily based out of Montclair, United States. As of Jul 2026, Cornucopian Capital is an active investor, having invested in 6 companies, with 2 new investments in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from HealthTech to Enterprise Applications and Life Sciences. Most recently it participated in the $***** Series B round of Handspring A lot of funds co-invest with Cornucopian Capital, with names like PeakBridge sharing a substantial percentage of its portfolio. Cornucopian Capital has team of 13 people including 4 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Seed & 1 more
Portfolio Soonicorns
Deals in last 12 months
Cornucopian Capital's List of Top Investments
Cornucopian Capital has a portfolio of 6 companies. Their most notable investmentis in Ilant HealthTheir portfolio spans across and United States. They have invested in HealthTech, Enterprise Applications, Life Sciences and 5 other sectors, across stages such as Series A, Seed and 1 more. Here is the list of top investments by Cornucopian Capital:
1. Handspring
Provider of mental health treatment and lifelong skill services. The platform offers video therapy sessions for treating children's and young adult mental health conditions such as anxiety & worries, depression & mood, behavioral difficulties, and more.
Key facts about Handspring
- Founded Year: 2021
- Location: New York City (United States)
- Stage: Series B
- Total Funding till date: $37.2M
- Employee Count: 77 as on Jul 31, 2026
- Investors: RPS Ventures, Cobalt Ventures and 9 Others
- Latest Funding Round: Series B, Jul 07, 2026, $*****
- Highlight: Editors' Pick
2. Ilant Health
Ilant Health is an obesity treatment company that offers a comprehensive solution to reduce the stress and stigma associated with obesity. They focus on increasing access to treatment while reducing the total cost of care for employers and payors.
Key facts about Ilant Health
- Founded Year: 2022
- Location: New York City (United States)
- Stage: Series A
- Total Funding till date: $22M
- Employee Count: 46 as on Jul 31, 2026
- Investors: Life Extension Ventures, naturalX Health Ventures and 12 Others
- Latest Funding Round: Series A, Jun 02, 2026, $*****
Provider of a platform to analyze a sample of blood and measure biochemical and physiological markers. It uses sophisticated algorithms and large scientific databases to determine optimal zones for each user’s markers. InsideTrack er’s expert system then provides science-driven lifestyle and nutrition interventions that empower people to optimize their markers.
Key facts about Segterra (InsideTracker)
- Founded Year: 2009
- Location: Cambridge (United States)
- Stage: Series B
- Total Funding till date: $17.5M
- Employee Count: 53 as on May 31, 2026
- Investors: BASF, OurCrowd and 4 Others
- Latest Funding Round: Series B, Sep 09, 2022, $*****
- Highlight: Editors' Pick
Developer of chemistry for automated small molecule discovery and manufacturing. It offers technology that transforms small-molecule innovation into a modular, iterative process. The technology facilitates automation, artificial intelligence integration, and use by non-specialists. It enables scaling from discovery to manufacturing. The offering includes chemical building blocks that allow automation to drive synthesis and accelerate discovery. It also provides AI-guided automated iterative synthesis and testing to maximize accuracy of models.
Key facts about Excelsior Sciences
- Founded Year: 2024
- Location: United States
- Stage: Series A
- Total Funding till date: $70M
- Employee Count: 25 as on Jul 31, 2026
- Investors: Deerfield, Lilly and 6 Others
- Latest Funding Round: Series A, Dec 03, 2025, $*****
- Highlight: Editors' Pick
5. Archon Bio
Provider of computational platform to develop protein therapeutics. It combines antibodies with AI-generated proteins and Antibody Cage that leverages geometric engineering to control biodistribution and engagement to develop therapeutic targets.
Key facts about Archon Bio
- Founded Year: 2023
- Location: Seattle (United States)
- Stage: Seed
- Total Funding till date: $20M
- Employee Count: 26 as on Jul 31, 2026
- Investors: Washington Research Foundation, Duke University and 5 Others
- Latest Funding Round: Seed, Oct 30, 2024, $*****
- Highlight: Editors' Pick
Cornucopian Capital's Year-on-Year Investment Trends
Cornucopian Capital has invested in 6 companies over the last 4 years, with an average of 1 new investment annually in the last 3 years. In 2025, it made 2 investments, while as of Jul 2026, it has made 2 investments in this year. Its most recent first time investment was in Ilant Health and most recent follow-on round was in Handspring.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 1 | 2 |
2025 | 2 | 0 | 2 |
2024 | 1 | 0 | 1 |
2023 | 0 | 0 | 0 |
2022 | 2 | 0 | 2 |
Cornucopian Capital's Investments by Stage
Cornucopian Capital has made 3 investments in Series A stage with an average round size of $32.3M, 2 investments in Seed stage with an average round size of $13.5M and 1 investment in Series B stage with an average round size of $15M.Stage of entry | No. of Investments |
|---|---|
Series A | 3 |
Seed | 2 |
Series B | 1 |
Note: We have considered here, only first round of investments
Cornucopian Capital's Investments by Sector
Cornucopian Capital has a diverse portfolio, with companies operating in the HealthTech, Enterprise Applications, Life Sciences, Consumer and Consumer Goods. Notably, it has invested in 4 Tech companies, 3 Software companies, 2 Consumer (B2C) companies and at least 2 companies focusing on Enterprise (B2B).Sector | No. of Investments |
|---|---|
HealthTech | 4 |
Enterprise Applications | 2 |
Life Sciences | 2 |
Consumer | 1 |
Consumer Goods | 1 |
Others | 3 |
Note: We have considered here, only first round of investments
Cornucopian Capital's Investments by Geography
Cornucopian Capital has made most investments in United States (6).Cornucopian Capital's recent investments
Cornucopian Capital has made 2 investments in 2026 so far - Handspring and Ilant Health.Here are the most recent investments by Cornucopian Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jul 07, 2026 | United States | Series B | 5876 | [+5] | |
Jun 02, 2026 | United States | Series A | 7121 | ||
Dec 03, 2025 | United States | Series A | 9800 | [+5] | |
Jun 27, 2025 | United States | Series A | 5561 | [+6] | |
Oct 30, 2024 | United States | Seed | 3014 | [+5] |
Team profile of Cornucopian Capital
Cornucopian Capital has a team of 13 members including 4 Partners and 2 Venture Partners located in United States. Cornucopian Capital's team does not sit on the board of any company as of now.Here is a list of top team members in Cornucopian Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Montclair | - | - | |
Partner | Jersey City | - | - | |
Partner | Minneapolis | - | - | |
Partner | United States | - | - | |
Venture Partner | Camas | - | - | |
Venture Partner | - | - | - |
Co-investors of Cornucopian Capital
Over the past 4 years, 53 investors have co-invested in Cornucopian Capital's portfolio companies. This includes funds and angels.
- Invested before Cornucopian Capital: NextView Ventures, 25madison and 10 others have invested in rounds before Cornucopian Capital. There is 1 company where NextView Ventures has invested before Cornucopian Capital and 1 company where 25madison has invested before Cornucopian Capital.
- Top Co-investors of Cornucopian Capital: 39 investors entered a company along with Cornucopian Capital. These include investors like PeakBridge (2 companies).
- Invested after Cornucopian Capital: RPS Ventures (1 company) and Angelini Ventures (1 company) are the investors which have invested in Cornucopian Capital's portfolio after their investments.
Recent News related to Cornucopian Capital
•
Ilant Health has raised $15 Million in new Series B fundingintelligence360•Jun 17, 2026•Ilant Health, Cornucopian Capital, naturalX Health Ventures, PeakBridge and 4 others
•
Obesity care startup Ilant Health raises $15MEndpoints•Jun 02, 2026•Ilant Health, Cornucopian Capital, Evidenced, naturalX Health Ventures and 7 others
•
•
Health startup Archon Bio raises $20 million in fundingWebrazzi•Oct 31, 2024•Archon Bio, Madrona, DUMAC, Sahsen Ventures and 4 others
•
Archon emerges from stealth with $20M and ‘antibody cages’ to power up drug developmentTechCrunch+•Oct 30, 2024•Archon Bio, Madrona, DUMAC, Sahsen Ventures and 4 others
•
•
Ilant Health Raises Another $2.5M for its Value-Based Care Platform for Obesity ManagementAlleyWatch•Apr 23, 2024•Ilant Health, Life Extension Ventures, Celtic House Asia Partners, Cornucopian Capital and 2 others
•
Cambridge-based healthspan optimization platform InsideTracker raises USD 15 million in Series B fundingVcbay News•Sep 10, 2022•Segterra (InsideTracker), PeakBridge, Cornucopian Capital, OurCrowd and 1 other
•
InsideTracker Raises $15M in FundingFinSMEs•Sep 09, 2022•Segterra (InsideTracker), PeakBridge, Cornucopian Capital, OurCrowd and 1 other
•
Nowadays Closes $7M Seed Funding RoundFinSMEs•Apr 20, 2022•Nowadays, Stray Dog Capital, Tenacious Ventures, Cornucopian Capital and 1 other
